The rush to find a coronavirus vaccine is on. AstraZeneca has resumed its trials after one participant fell ill. Meanwhile, Russia is set to trial its vaccine candidate on 40,000 people, though as FRANCE 24 health editor Julia Sieger explains, some experts are sceptical of the methodology.
You may also like
